ARTHROPLASTY
Continuous passive motion after TKA may lack postoperative benefits vs. standard treatment
J Arthroplasty. 2015 Dec;30(12):2364-9109 patients scheduled to undergo TKA were randomized to receive or not receive continuous passive motion (CPM) treatment during postoperative therapy. The purpose of this study was to determine the efficacy of the proposed short-term benefits CPM by means of measuring the active range of motion (AROM), pain, and discharge disposition after a follow-up period of 3 months. Results demonstrated that there were no significant clinical differences between study groups with respect to with to the aforementioned outcomes, suggesting that standard use of CPM provide no clinically relevant advantages.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
